Financials
- Financial year
- 2025
- Total assets
- €1.1m
- Profit
- €145,818
- Solvency
- 64.6%
Total assets▼ 1.8%
Net result
20192025
DR.CAROLINE MAES
ActiveSummary
DR.CAROLINE MAES has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €686,418 and a net result of €145,818. Equity is growing by about 15% per year across the filed financial years. Its solvency ranks better than 52% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Activity
Specialist medical practice
NACE 86220
4th largest company by total assets in Ranst, Health and social work sector2 sites
Size
€1.1mtotal assets 2025
- Staff
- 1 FTE
- Equity
- €686,418
- Profit
- €145,818
Turnover not published (micro format)
Structure
2025 accounts 1 day early3 deeds in the Belgian Official Gazette
Why 93raises riskLiquidity: current ratio 2.84, cash €25,811lowers riskSector: Human health activities (NACE 86)Size: total assets €1.1mFigures for financial year 2025 (filed 30-01-2026)Show the evidence
Checked score
Score 2025
93
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 41% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency
90+7
equity 64.6% of total assets
Liquidity
51+1
short-term debt 13.9% · cash 2.4%
Profitability
86+6
return on assets 13.7%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.1%
12-2024: 0.1%● unchanged vs 11-2024
01-2025: 0.1%● unchanged vs 12-2024highest value
02-2025: < 0.1%▼ -0.1 percentage points vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: 0.1%▲ +0.1 percentage points vs 12-2025
02-2026: < 0.1%▼ -0.1 percentage points vs 01-2026lowest value
03-2026: < 0.1%● unchanged vs 02-2026lowest value
04-2026: < 0.1%● unchanged vs 03-2026lowest value
05-2026: < 0.1%● unchanged vs 04-2026lowest value
06-2026: < 0.1%● unchanged vs 05-2026lowest value
07-2026: < 0.1%● unchanged vs 06-2026lowest value
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €60,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.84, compared with 2.62 in 2024, above the usual 1.5; short-term debt: 13.9% and cash: 2.4% of total assets), and 35.4% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 52% on solvency, 23% on liquidity, 37% on profitability and 52% on growth.
The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 day early
2024
on the day
2023
2 days early
2022
1 day early
2021
on the day
2020
3 days early
2019
1 day early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 1 day before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 30 January (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
30-06-2026 year end25-10-2026 today31-01-2027 deadline
- Annual accounts filedfinancial year 2025 · micro…
- Annual accounts filedfinancial year 2024 · micro…
- Annual accounts filedfinancial year 2023 · micro…
Key points
- Positive: Among the best 12% on equitysector median €124,501 · 20,606 companies €686,418 View
- Positive: Result rose in 2025from €94,962 to €145,818 ▲ 53.6% View
- Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
- Positive: 7 profitable years in a rowprofit 2025: €145,818 7 years View
By topic
Timeline
- Events
- 18
- Since
- 2012
- Next accounts
- by 31-01-2027
- 30-06-2023Weakest financial year
- 30-01-2023Annual accounts filed
- 30-06-2022Equity above €500,000
Company details
- Sites
- 2
- Legal form
- Private limited company
- Activity
- Specialist medical practiceNACE 86220
- Founded
- 25-11-2009
- Year ends
- 30-06
- Peppol
- Not found in the Peppol directory
Key facts about DR.CAROLINE MAES
- What is the company number of DR.CAROLINE MAES?
- 0820.894.370. In Belgium the VAT number is the company number with BE in front: BE 0820.894.370.
- Where is DR.CAROLINE MAES based?
- The registered office is at Liersesteenweg 56, 2520 Ranst.Company details
- What does DR.CAROLINE MAES do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR.CAROLINE MAES?
- Private limited company (BV).
- When was DR.CAROLINE MAES founded?
- On 25-11-2009.
- Is DR.CAROLINE MAES still active?
- Yes, DR.CAROLINE MAES is an active enterprise in the KBO register.
- How many employees does DR.CAROLINE MAES have?
- On average 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of DR.CAROLINE MAES?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
- Is DR.CAROLINE MAES profitable?
- In financial year 2025, DR.CAROLINE MAES made a profit of €145,818.
- Where can I find the annual accounts of DR.CAROLINE MAES?
- DR.CAROLINE MAES filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR.CAROLINE MAES due?
- By 31-01-2027, for financial year 2026.Timeline
Companies related to DR.CAROLINE MAES
Comparable companies
- Dr. R. Tavernier, CardiologieZwalm
- Institut FovéaVorst
- OOGARTS JULIE WITTERSGent
- Dr. Ruben Claeys, RadiologieLiedekerke
- C. Bert, AnesthesieAalst
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.